Matthew O’Connor of Cyclarity tells us how his company is curing cardiovascular disease (podcast)

Podcast - play here:

More info/ Company website:

1 Like

And the previous monthy’s Translating aging podcast:

Podcast - play here:

Company website:

Translating Aging Podcast - Links to the major podcast platforms:

Apple Podcasts:
https://podcasts.apple.com/us/podcast/translating-aging/id1569628505…

Google Podcasts: https://podcasts.google.com/feed/aHR0cHM6Ly9iaW9hZ2UuY2FwdGl2YXRlLmZtL3Jzc2ZlZWQ…

Spotify: https://open.spotify.com/show/1AjX0G0C9r1KIaMkB4A9lNNLRP3

1 Like

New on VitaDAO:

One-liner : Cyclarity Therapeutics is an early stage biotechnology company developing computationally designed novel cyclodextrin drug molecules for the extraction of toxic biomolecules that accumulate with age and are implicated in a variety of age-related conditions including cardiovascular disease, macular degeneration, stroke, and liver failure.

https://snapshot.org/#/vote.vitadao.eth/proposal/0xeafce7c4610f9398048d7ed93d0bc5a083956224eec5f4e8f7ed5152f9f631d1